EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

FDG-PET in the Evaluation of Primary Progressive Aphasia: A Narrative Review

Alexandros Giannakis iD, Emmanouil Anyfantis, Eleni Litsou iD, Chrissa Sioka iD, Spyridon Konitsiotis iD

Medicina · 22.04.2026 · 62 (5) · 800

DOI: 10.3390/medicina62050800 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicina, online erschienen am 22.04.2026. Verfasst von Alexandros Giannakis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Stavrou Niarchou Av., 45500 Ioannina, Greece. Hauptthemen laut MEDLINE: Aphasia, Primary Progressive, Positron-Emission Tomography, Fluorodeoxyglucose F18. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Primary progressive aphasia (PPA) and its variants—logopenic (lvPPA), semantic (svPPA), and nonfluent/agrammatic (nfvPPA)—are progressive neurocognitive syndromes characterized by predominant language impairment and associated with heterogeneous underlying neuropathologies. Accurate diagnosis remains challenging due to overlapping clinical features and complex pathobiological mechanisms. Fluorodeoxyglucose positron emission tomography (FDG-PET), which reflects regional cerebral glucose metabolism, may provide valuable insights into both the diagnosis and pathophysiological characterization of PPA. Materials and Methods: We reviewed the current literature and identified 48 original research articles that utilized FDG-PET in the evaluation of at least one PPA variant. Eight studies focused exclusively on lvPPA, six on svPPA, and two on nfvPPA, either alone or in comparison with other neurodegenerative diseases. Eighteen studies evaluated at least two PPA variants, while thirteen compared multiple PPA variants with other neurodegenerative disorders.

Results

Most studies identified characteristic hypometabolic patterns for each PPA variant: left temporoparietal regions in lvPPA, bilateral anterior temporal regions with left predominance in svPPA, and left posterior frontal regions in nfvPPA. These variant-specific metabolic signatures may support differential diagnosis. Additionally, FDG-PET provided important insights into disease progression, including associations with worsening language impairment, evolution toward broader neurodegenerative syndromes, and correlations with specific neurocognitive deficits. These findings are largely consistent with other neuroimaging modalities and disease-specific biomarkers. However, limitations such as small sample sizes and the lack of autopsy confirmation in most studies limit the robustness of the results.

Conclusions

FDG-PET appears to be a valuable tool for the diagnosis, differential diagnosis, and pathophysiological understanding of PPA. Nevertheless, large-scale, multicenter investigations incorporating pathologically confirmed cases to further validate its clinical utility are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aphasia, Primary ProgressivePositron-Emission TomographyFluorodeoxyglucose F18Humans

Stichwörter der Autor:innen

Alzheimer’s diseasefluorodeoxyglucose positron emission tomographyfrontotemporal lobar degenerationneuroimaging biomarkersprimary progressive aphasia

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Neurology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Stavrou Niarchou Av., 45500 Ioannina, Greece.
  • Department of Speech Language Therapy, School of Health Sciences, University of Ioannina, Stavrou Niachou Av., 45500 Ioannina, Greece.
  • Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Ioannina, Stavrou Niarchou Av., 45500 Ioannina, Greece.
  • Department of Nuclear Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Stavrou Niarchou Av., 45500 Ioannina, Greece.

ORCID-Profile: Alexandros Giannakis, Eleni Litsou, Chrissa Sioka, Spyridon Konitsiotis

Zitieren

APA

Giannakis, A., Anyfantis, E., Litsou, E., Sioka, C., & Konitsiotis, S. (2026). FDG-PET in the Evaluation of Primary Progressive Aphasia: A Narrative Review. Medicina, 62(5), 800. https://doi.org/10.3390/medicina62050800

Vancouver

Giannakis A, Anyfantis E, Litsou E, Sioka C, Konitsiotis S. FDG-PET in the Evaluation of Primary Progressive Aphasia: A Narrative Review. Medicina. 2026;62(5):800. doi:10.3390/medicina62050800

BibTeX
@article{Giannakis2026,
  author = {Giannakis, Alexandros and Anyfantis, Emmanouil and Litsou, Eleni and Sioka, Chrissa and Konitsiotis, Spyridon},
  title = {FDG-PET in the Evaluation of Primary Progressive Aphasia: A Narrative Review},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {5},
  pages = {800},
  doi = {10.3390/medicina62050800}
}
Kostenlos starten →